title: Primary cerebral Whipple disease presenting as Klüver-Bucy syndrome.
authors.affiliation: Division of Neurogenetics, Department of Neurology, 403 E 34th St, 2nd Floor, New York, NY 10016, USA.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Leesch
authors.forename: Ingeborg
authors.initials: I
authors.lastname: Fischer
authors.forename: Robert
authors.initials: R
authors.lastname: Staudinger
authors.forename: Douglas C
authors.initials: DC
authors.lastname: Miller
authors.forename: Swati
authors.initials: S
authors.lastname: Sathe
mesh_terms: D000679:Amygdala / Q000382:microbiology / Q000473:pathology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D003704:Dementia / Q000382:microbiology / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D020232:Kluver-Bucy Syndrome / Q000382:microbiology* / Q000473:pathology* / Q000503:physiopathology; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D010291:Paresis / Q000382:microbiology / Q000473:pathology; D013702:Temporal Lobe / Q000382:microbiology* / Q000473:pathology*; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D008061:Whipple Disease / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002443:Ceftriaxone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination